CN109479958A - A kind of refrigerant Yoghourt and preparation method thereof for controlling abscess of throat - Google Patents
A kind of refrigerant Yoghourt and preparation method thereof for controlling abscess of throat Download PDFInfo
- Publication number
- CN109479958A CN109479958A CN201811268967.2A CN201811268967A CN109479958A CN 109479958 A CN109479958 A CN 109479958A CN 201811268967 A CN201811268967 A CN 201811268967A CN 109479958 A CN109479958 A CN 109479958A
- Authority
- CN
- China
- Prior art keywords
- milk
- yoghourt
- cow
- throat
- cream
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013618 yogurt Nutrition 0.000 title claims abstract description 113
- 206010000269 abscess Diseases 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 239000003507 refrigerant Substances 0.000 title claims description 14
- 235000013336 milk Nutrition 0.000 claims abstract description 37
- 239000008267 milk Substances 0.000 claims abstract description 37
- 210000004080 milk Anatomy 0.000 claims abstract description 37
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 31
- 238000000855 fermentation Methods 0.000 claims abstract description 25
- 240000000111 Saccharum officinarum Species 0.000 claims abstract description 23
- 235000007201 Saccharum officinarum Nutrition 0.000 claims abstract description 23
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 claims abstract description 22
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims abstract description 21
- 230000001954 sterilising effect Effects 0.000 claims abstract description 21
- 235000009434 Actinidia chinensis Nutrition 0.000 claims abstract description 20
- 235000013087 Plumeria rubra Nutrition 0.000 claims abstract description 20
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 20
- 235000021028 berry Nutrition 0.000 claims abstract description 20
- 241000220324 Pyrus Species 0.000 claims abstract description 19
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 18
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 18
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 18
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 18
- 235000021017 pears Nutrition 0.000 claims abstract description 18
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 16
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 16
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 13
- 240000000249 Morus alba Species 0.000 claims abstract description 13
- 238000001816 cooling Methods 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 238000012545 processing Methods 0.000 claims abstract description 9
- 238000011081 inoculation Methods 0.000 claims abstract description 8
- 239000012535 impurity Substances 0.000 claims abstract description 7
- 238000007711 solidification Methods 0.000 claims abstract description 7
- 230000008023 solidification Effects 0.000 claims abstract description 7
- 238000005057 refrigeration Methods 0.000 claims abstract description 4
- 244000234609 Portulaca oleracea Species 0.000 claims abstract 6
- 244000215777 Plumeria rubra Species 0.000 claims abstract 5
- 244000298715 Actinidia chinensis Species 0.000 claims abstract 3
- 235000020247 cow milk Nutrition 0.000 claims description 43
- 239000006071 cream Substances 0.000 claims description 31
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 27
- 241000894006 Bacteria Species 0.000 claims description 25
- 230000004151 fermentation Effects 0.000 claims description 24
- 235000020185 raw untreated milk Nutrition 0.000 claims description 24
- 241000219109 Citrullus Species 0.000 claims description 22
- 239000004615 ingredient Substances 0.000 claims description 19
- 229930006000 Sucrose Natural products 0.000 claims description 17
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 17
- 239000005720 sucrose Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000004310 lactic acid Substances 0.000 claims description 15
- 235000014655 lactic acid Nutrition 0.000 claims description 15
- 238000004659 sterilization and disinfection Methods 0.000 claims description 14
- 235000000346 sugar Nutrition 0.000 claims description 13
- 235000019640 taste Nutrition 0.000 claims description 13
- 238000009835 boiling Methods 0.000 claims description 12
- 235000020183 skimmed milk Nutrition 0.000 claims description 12
- 238000003860 storage Methods 0.000 claims description 12
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 11
- 239000001963 growth medium Substances 0.000 claims description 11
- 239000002054 inoculum Substances 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 10
- 238000012856 packing Methods 0.000 claims description 10
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 238000004090 dissolution Methods 0.000 claims description 7
- 238000000265 homogenisation Methods 0.000 claims description 7
- 230000032683 aging Effects 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 235000019634 flavors Nutrition 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- 229910001220 stainless steel Inorganic materials 0.000 claims description 6
- 239000010935 stainless steel Substances 0.000 claims description 6
- 210000000265 leukocyte Anatomy 0.000 claims description 5
- 239000004033 plastic Substances 0.000 claims description 5
- 241000194017 Streptococcus Species 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims 2
- 239000003814 drug Substances 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 21
- 229940079593 drug Drugs 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 235000019658 bitter taste Nutrition 0.000 abstract description 5
- 235000008216 herbs Nutrition 0.000 abstract description 4
- 244000241235 Citrullus lanatus Species 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 210000003800 pharynx Anatomy 0.000 description 28
- 239000007788 liquid Substances 0.000 description 19
- 244000298697 Actinidia deliciosa Species 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 18
- 238000010790 dilution Methods 0.000 description 18
- 239000012895 dilution Substances 0.000 description 18
- 239000000284 extract Substances 0.000 description 18
- 229920003266 Leaf® Polymers 0.000 description 16
- 244000071969 Plumeria obtusa Species 0.000 description 15
- 241000219304 Portulacaceae Species 0.000 description 15
- 206010061218 Inflammation Diseases 0.000 description 12
- 230000004054 inflammatory process Effects 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 12
- 238000007789 sealing Methods 0.000 description 12
- 230000008961 swelling Effects 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- 230000003110 anti-inflammatory effect Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 239000002158 endotoxin Substances 0.000 description 9
- 229920006008 lipopolysaccharide Polymers 0.000 description 9
- 241001478240 Coccus Species 0.000 description 8
- 102000003777 Interleukin-1 beta Human genes 0.000 description 8
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 8
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 230000002757 inflammatory effect Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 238000002965 ELISA Methods 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 108090000193 Interleukin-1 beta Proteins 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 230000001754 anti-pyretic effect Effects 0.000 description 6
- 239000002221 antipyretic Substances 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 6
- 230000000875 corresponding effect Effects 0.000 description 6
- 210000002540 macrophage Anatomy 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 238000008157 ELISA kit Methods 0.000 description 5
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- LXBIFEVIBLOUGU-JGWLITMVSA-N duvoglustat Chemical group OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O LXBIFEVIBLOUGU-JGWLITMVSA-N 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000004321 preservation Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 206010013789 Dry throat Diseases 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 101001033286 Mus musculus Interleukin-1 beta Proteins 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 244000179560 Prunella vulgaris Species 0.000 description 3
- 235000010674 Prunella vulgaris Nutrition 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 210000000867 larynx Anatomy 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 239000006041 probiotic Substances 0.000 description 3
- 235000018291 probiotics Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000003248 secreting effect Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241000207923 Lamiaceae Species 0.000 description 2
- 101000648740 Mus musculus Tumor necrosis factor Proteins 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 2
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000009514 concussion Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 235000015092 herbal tea Nutrition 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- HVAUUPRFYPCOCA-AREMUKBSSA-N 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C HVAUUPRFYPCOCA-AREMUKBSSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- ZHQQRIUYLMXDPP-SSDOTTSWSA-N Actinidine Natural products C1=NC=C(C)C2=C1[C@H](C)CC2 ZHQQRIUYLMXDPP-SSDOTTSWSA-N 0.000 description 1
- 241000410338 Ajuga decumbens Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000226624 Boea Species 0.000 description 1
- 241000255791 Bombyx Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010007027 Calculus urinary Diseases 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 206010023848 Laryngeal pain Diseases 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 206010028817 Nausea and vomiting symptoms Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108010003541 Platelet Activating Factor Proteins 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000951473 Schizonepeta Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010049713 Tongue dry Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 241001643642 Viticis Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- ZHQQRIUYLMXDPP-ZETCQYMHSA-N actinidine Chemical compound C1=NC=C(C)C2=C1[C@@H](C)CC2 ZHQQRIUYLMXDPP-ZETCQYMHSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 238000001827 electrotherapy Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000003500 flue dust Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- -1 hp-CRP Proteins 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940012969 lactobacillus fermentum Drugs 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000003300 oropharynx Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 238000004634 pharmacological analysis method Methods 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000010181 polygamy Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 208000008281 urolithiasis Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 235000008924 yoghurt drink Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/133—Fruit or vegetables
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/143—Fermentum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Dairy Products (AREA)
Abstract
The invention belongs to yogurt production technical fields, disclose a kind of cold-type yellow (clear) Yoghourt for treating abscess of throat and preparation method, raw material fresh milk is purified, adjust fat standardising, middle addition Wan Niangan after impurity screening, radix polygonati officinalis, purslane, frangipanis, summer mushroom grass, mulberry leaf, peppermint, watermelon peel, Kiwi berry, pears, filtered juice made of sugarcane, carrying out homogeneous, sterilizing, inoculation processing, for solidification type yoghourt, first dispense post-fermentation, it is cooled down again, after-ripening, refrigeration, Yoghourt is made, for stirred yoghurt, it first ferments and dispenses afterwards, Yoghourt is made after carrying out cooling again.The present invention passes through two kinds of yogurt production modes, make Yoghourt that there is the specific function for the treatment of abscess of throat, people can only can achieve the effect that treat abscess of throat by the Yoghourt drunk in this way, without spending many time to go to buy medicine and decocting medicinal herbs, not have to the bitter taste for enduring drug also.
Description
Technical field
The invention belongs to yogurt production technical field more particularly to a kind of preparation sides for the refrigerant Yoghourt for controlling abscess of throat
Method.
Background technique
Currently, the prior art commonly used in the trade is such that
In autumn and winter, weather is very dry, it is easy to the phenomenon that abscess of throat occurs.Abscess of throat is oropharynx and laryngopharynx portion
The cardinal symptom of lesion, characterized by bottleneck throat congestion and swelling pain, swallowing discomfort, also known as " sore throat ".Abscess of throat is that people are most normal
There are many one of disease symptoms seen, the reason of causing, such as do not pay attention to and excessively use larynx on flu, tonsillitis, diet
Deng now with the drugs and folk prescription of many treatment sphagitis, many people are also selected at family and look for a medicine or buy to pharmacy
Point medicine is eaten.It is quick that Western medicine treats any disease all since ancient times, but side effect is big, and dependence can be generated by taking Western medicine for a long time
With so that body is generated certain resistance to a certain drug.Chinese medicine is adjusted in focusing on, but it is relatively slow to take effect, and Chinese medicine is typically all to decoct
It is more troublesome.Chinese and Western medicine has bitter taste, especially Chinese medicine, and many people are difficult to take, especially child.
Yoghourt is that a certain proportion of sucrose is added using fresh milk as raw material, after high temperature sterilization is cooling, is added
A kind of dairy produce made of pure lactic acid bacteria culturers culture, taste is sour-sweet fine and smooth, full of nutrition.Its nutritive value is better than fresh milk
With various milk powder.The certain strains of fermentation process make sugar, protein in milk have 20% or so to be hydrolyzed into for small molecule (such as gala
Sugar and lactic acid, small peptide chain and amino acid etc.).Fat content is usually 3%-5% in milk.Fatty acid after fermented, in cream
Increase by 2 times than raw material milk.These variations keep Yoghourt more easy to digest and absorb, and the utilization rate of various nutrients is improved.Acid
Milk is fermented by plain chocolate, and in addition to the whole nutritional ingredients for remaining fresh milk, lactic acid bacteria also be can produce during the fermentation
Multivitamin necessary to human nutrition, such as VB1, VB2, VB6, VB12.
Due to the rapid development of science and technology, people are distinctly understood that, the food composition that many is beneficial to health,
And various diseases generation and diet correlation, and by improve diet condition and play food itself physiology tune
Function is saved, and achievees the purpose that improve human health.The particular matter with unique effects is added in Yoghourt, Yoghourt can be made
With unique function, so that functional yoghourt be made.Therefore the substance that can alleviate abscess of throat is added in Yoghourt, makes
Yoghourt has the specific function for the treatment of abscess of throat, and such people only can reach treatment pharynx by the Yoghourt drunk
The effect of larynx swelling and pain does not have to the bitter taste for enduring drug also without spending many time to go to buy medicine and decocting medicinal herbs.
In conclusion problem of the existing technology is:
Abscess of throat is one of most common disease symptoms of people, whenever sick, need specially to buy medicine and take;Western medicine pair is made
With big, long-term use can generate dependence and body is made to generate certain resistance to a certain drug;Chinese medicine takes effect relatively slowly, and in
Medicine typically decocts more troublesome;Chinese and Western medicine has bitter taste, especially Chinese medicine, and many people are difficult to take, especially child.
Solve the difficulty and meaning of above-mentioned technical problem:
On the one hand main difficulty of the invention is the combination by milk and Chinese medicine and utilizes the fermentation in production process
Process removes dense flavour of a drug, and as addition sucrose and fruit juice (watermelon peel, Kiwi berry, pears and sugar cane crushing) come obtained by making
The yoghourt-flavored arrived is pure, clean taste.Further aspect is that effect of the invention, especially vitro detection are examined, the present invention
It is swollen that treatment throat is observed by establishing the external inflammatory model of lipopolysaccharides (LPS) stimulating expression of macrophage strain RAW246.7 activation
The anti-inflammatory effect of pain Yoghourt.If launch is made in the present invention, a kind of new side for improving abscess of throat state will be brought
Formula, the state for allowing people to pass through a kind of method of light pleasure to keep fit.
Summary of the invention
In view of the problems of the existing technology, the present invention provides a kind of functional yoghourts for treating abscess of throat.
The invention is realized in this way a kind of functional yoghourt for treating abscess of throat, solidification type yoghourt preparation method,
Include:
Step 1, the processing of ingredient: preparation filtered juice.By Wan Niangan, purslane, frangipanis, peppermint and folium mori homogenate after
It filters filter residue and takes juice, watermelon peel, Kiwi berry, pears and sugar cane crushing take juice.Each raw material is that (gross mass is by weight percentage
250g): Wan Niangan 5%~10%, radix polygonati officinalis 5%~8%, frangipanis 3%~5%, summer mushroom grass 3%~5%, purslane 3%~
5%, (or Kiwi berry, pears, sugarcane, note: this ingredient is to have Yoghourt for peppermint 8%~15%, mulberry leaf 5%~10%, watermelon peel
A series of different tastes) 6%~10%, starting milk 50%~65%, sucrose 3%~5%;
Milk bottle disinfection: step 2 milk bottle is used boiling water boiling 15 minutes in stainless-steel pan;
Step 3, the purification of cow's milk: with specially designed centrifuge, the white blood cell removed in cow's milk is visible with other naked eyes
Foreign matter;
Normalising fat content: step 4 the skimmed milk of certain volume is added in the high cow's milk of fat content, or passes through
Seperator isolates dilute cream from cow's milk, then mixes a certain amount of dilute cream again in obtained skimmed milk;
Step 5, ingredient: being heated to 60 DEG C or so for raw milk, and the sucrose of 3%-5%, sugar dissolution are added in modulation cream
Afterwards, then filtering and impurity removing adds the filtered juice of step 1 preparation;
Two methods of heating and the appropriate combination of homogeneous are got up to handle, raw milk are first adjusted to 60 DEG C of left sides by step 6, homogeneous
The right side carries out homogenization to cream in 8~10Mpa pressure then in homogenizer;
Step 7, sterilizing: there are two types of the sterilizing methods of the raw milk after homogeneous, and cream is heated to 90 DEG C, keeps the temperature 5min, or
It is placed in 80 DEG C of thermostat water baths and sterilizes 15 minutes, or use ultra high temperature short time sterilization method (keeping the temperature 2~3s at 135 DEG C);
Inoculation: the working stock culture that inoculum concentration is 2~3% is added in step 8 in the raw milk sterilized to 43~45 DEG C.
For the Mixed Microbes of streptococcus thermophilus and lactobacillus fermenti, the ratio of two kinds of bacterium is 1:1 or 2:1.The inoculum concentration of coccus is slightly some more, can be more
It mends since bacillus grows the shortcomings that producing acid and hindering coccus lazy weight caused by coccus growth;
Packing: cow's milk culture medium containing lactic acid bacteria in desinfection chamber, is first dispensed into the vial of sale by step 9
Or in plastic small container, thermostatic chamber culture is sent into after capping, Yoghourt is made in fermentation in a reservoir.After cow's milk packing, upper vessel portion
The gap reserved wants as small as possible, and the time of operation wants short;
Step 10, fermentation: the container equipped with lactobacteria-containing cow's milk being placed in insulating box and is fermented, the temperature of insulating box
Degree is maintained at 40~43 DEG C, and the time is 3~4 hours;
Step 11, cooling: fermentation ends are answered before Yoghourt shifting to be put into refrigerating chamber and carries out storage and Aging storage
Yoghourt is taken out from fermenting cellar, is cooled to 10 DEG C rapidly with cold wind hereinafter, the lactic acid bacteria in Yoghourt is made to stop growing;
Step 12, after-ripening: Yoghourt should be kept for 24 hours or more after forming grumeleuse at 4~7 DEG C;
Step 13, refrigeration: the Yoghourt through cooling treatment is housed in 2~5 DEG C, and preferably -1~0 DEG C of refrigerating chamber saves;
Step 14, taste: if there is smell, being likely to Yoghourt polluted miscellaneous bacteria.
Another object of the present invention is to provide a kind of functional yoghourt for treating abscess of throat, stirred yoghurt preparations
Method, comprising:
Step 1, the processing of ingredient: preparation filtered juice.By Wan Niangan, purslane, frangipanis, peppermint and folium mori homogenate after
It filters filter residue and takes juice, watermelon peel, Kiwi berry, pears and sugar cane crushing take juice.Each raw material is that (gross mass is by weight percentage
250g): Wan Niangan 5%~10%, radix polygonati officinalis 5%~8%, frangipanis 3%~5%, summer mushroom grass 3%~5%, purslane 3%~
5%, (or Kiwi berry, pears, sugarcane, note: this ingredient is to have Yoghourt for peppermint 8%~15%, mulberry leaf 5%~10%, watermelon peel
A series of different tastes) 6%~10%, starting milk 50%~65%, sucrose 3%~5%;
Milk bottle disinfection: step 2 milk bottle is used boiling water boiling 15 minutes in stainless-steel pan;
Step 3, the purification of cow's milk: utilizing specially designed centrifuge, removes the white blood cell in cow's milk and other visually may be used
The foreign matter seen;
Normalising fat content: step 4 the skimmed milk of certain volume is added in the high cow's milk of fat content, or passes through
Seperator isolates dilute cream from cow's milk, then mixes a certain amount of dilute cream again in obtained skimmed milk;
Ingredient: step 5 the sucrose of 4%-8% is added in modulation cream, raw milk is first heated to 60 DEG C or so, then
Sucrose is added, after sugar dissolution, then filtering and impurity removing adds the filtered juice of step 1 preparation;
Step 6, homogeneous: the raw milk for making Yoghourt passes through homogenization, and butter oil is dispersed throughout.It will heating
Get up processing with two methods of the appropriate combination of homogeneous, raw milk is first adjusted to 60 DEG C or so, then in homogenizer, in 8~
10Mpa pressure carries out homogenization to cream;
Step 7, sterilizing: there are two types of the sterilizing methods of the raw milk after homogeneous, and cream is heated to 90 DEG C, keeps the temperature 5 minutes,
Or it is placed in 80 DEG C of thermostat water baths and sterilizes 15 minutes;(2~3 can also be kept the temperature at 135 DEG C with ultra high temperature short time sterilization method
Second);
Step 8, inoculation: being added the working stock culture that inoculum concentration is 2~3% in the raw milk sterilized to 43~45 DEG C,
For the Mixed Microbes of streptococcus thermophilus and lactobacillus fermenti, the ratio of two kinds of bacterium is 1:1 or 2:1.The inoculum concentration of coccus is slightly some more;
Step 9, fermentation: the container equipped with lactobacteria-containing cow's milk being placed in insulating box and is fermented, the temperature of insulating box
Degree is maintained at 40~43 DEG C, and the time is 3~4 hours;
Step 10, stirring: being stirred into cup for the cow's milk containing lactic acid bacteria and contain in other containers, product curd particle diameter
It is maintained at 0.01~0.04mm size;
Packing: cow's milk culture medium containing lactic acid bacteria in desinfection chamber, is first dispensed into the glass of sale by step 11
In bottle or plastic small container, thermostatic chamber culture is sent into after capping, Yoghourt is made in fermentation in a reservoir.After cow's milk packing, on container
The gap that portion reserves wants as small as possible, and the time of operation wants short;
Step 12, cooling: fermentation ends are answered before Yoghourt shifting to be put into refrigerating chamber and carries out storage and Aging storage
Yoghourt is taken out from fermenting cellar, is cooled to 10 DEG C or less rapidly with cold wind.
In conclusion advantages of the present invention and good effect are as follows:
1. the present invention by Wan Niangan, purslane, frangipanis, summer mushroom grass, mulberry leaf, radix polygonati officinalis, peppermint, watermelon peel, Kiwi berry,
Filtered juice made of pears, sugarcane, which is added in milk, carries out the Yoghourt that fermentation preparation has treatment abscess of throat.Polysaccharide in sugarcane, ten thousand
Galactolipin, arabinose, the xylose of Nian Ganzhong, the vitamin etc. in sugarcane can promote the proliferation of Lactis In Yoghurt, facilitate
Yoghourt fermentation, and can increase the proliferation of the probiotics in the probiotics and enteron aisle in Yoghourt after drinkable yoghourt, while watermelon peel
In dietary fiber can promote intestinal movement, promote toxin to excrete, improve intestinal microflora, facilitate probiotics inhibition
Harmful bacteria has antiinflammation plant extraction filtrate synergistic effect with purslane, summer mushroom grass etc., significantly increases antiinflammation.
On the other hand, mulberry-leaf extract 1-Deoxynojirimycin forms a kind of novel substance in conjunction with the flavones in radix polygonati officinalis, summer mushroom grass --- it washes
The clear sugar of pancreas is plain (cics), has the effects that antibacterial anti-inflammatory;Mulberry-leaf extract inhibits the work of pathogenic bacteria under the acid condition of Yoghourt
Property significantly increases.Kiwi berry rich in vitamin C facilitate it is antiviral, inhibit virus infection, enhance the immunity of body;It ties up simultaneously
Raw element C has oxidation resistant function, and oxidized form of glutathione can be made to be reduced into reduced glutathione, plays antioxidation,
The sterilizing ability for enhancing body neutrophil leucocyte, quickly inhibits inflammation.
2. 4~7 DEG C have the advantage that in low temperature After-ripening for low temperature after-ripening 24 hours, Yoghourt after Yoghourt fermentation solidification
Fragrance matter gradually forms, and with the fragranced material mixing in plant extraction filtrate, armaticity flavor substance ratio is appropriate, makes acid
Milk has compared with giving off a strong fragrance taste.And the acidity of Yoghourt rises few during after-ripening;Convergent force can be generated when Coagulation of milk, lead to whey
It folds, in low temperature, this convergent force is weaker, so whey is not easy to separate from Yoghourt;Yoghourt gradually forms under low temperature
Structural state as white jade, structure are very fine and smooth.
3. food-borne Chinese herbal medicine has many good qualities as additive: naturality, it is pollution-free and be conducive to environmental protection;It is multi-functional
Property;Bidirectional modulation;Nontoxic secondary residual and nothing " three cause ";Without drug resistance;It is integrally-regulated and excitation transfer body in it is positive
Factor.The Chinese herbal medicine substance that can alleviate abscess of throat is added in Yoghourt, Yoghourt and its inhibiting bacteria and diminishing inflammation ingredient is made to act synergistically,
With effective specific function for inhibiting abscess of throat, diminishing inflammation, Yoghourt that such people can only by drinking
Achieve the effect that treat abscess of throat, without spending many time to go to buy medicine and decocting medicinal herbs, does not have to the bitter taste for enduring drug also.
Detailed description of the invention
Fig. 1 is solidification type yoghourt preparation method process in the refrigerant Yoghourt provided in an embodiment of the present invention for controlling abscess of throat
Figure.
Fig. 2 is stirred yoghurt production flow diagram provided in an embodiment of the present invention.
Specific embodiment
In order to further understand the content, features and effects of the present invention, the following examples are hereby given, and cooperate attached drawing
Detailed description are as follows.It should be appreciated that the specific embodiments described herein are merely illustrative of the present invention, it is not used to limit this
Invention.
Zymophyte of the invention: lactobacillus fermenti (Lactobacillusfermentum), deposit number CGMCC
No.8214 was deposited in China Committee for Culture Collection of Microorganisms's common micro-organisms center, preservation on 09 17th, 2013
Address is Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3, Institute of Microorganism, Academia Sinica.
Streptococcus thermophilus (Streptococcus thermophiles) of the invention, is purchased from Chinese microorganism strain preservation
Administration committee's common micro-organisms center, address are as follows: Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3, Chinese Academy of Sciences microorganism
Research institute.
The refrigerant Yoghourt provided in an embodiment of the present invention for controlling abscess of throat, each raw material are that (gross mass is by weight percentage
250g): Wan Niangan 5%~10%, radix polygonati officinalis 5%~8%, frangipanis 3%~5%, summer mushroom grass 3%~5%, purslane 3%~
5%, (or Kiwi berry, pears, sugarcane, note: this ingredient is to have Yoghourt for peppermint 8%~15%, mulberry leaf 5%~10%, watermelon peel
A series of different tastes) 6%~10%, starting milk 50%~65%, sucrose 3%~5%, lactobacillus fermenti 6%~
10% and streptococcus thermophilus 3%~9% form.This is that each constituent of Yoghourt accounts for the percentage of Yoghourt total weight, wherein fermenting
Lactobacillus 6%~10% and streptococcus thermophilus 3%~9% are lactobacillus fermenti and streptococcus thermophilus by 1:1 or 2:1 Bijie with
After the inoculum concentration inoculation of 2-3%, during fermented yoghourt, after both bacterium grown a period of time, each total weight of Yoghourt is accounted for
Percentage.
As shown in Figure 1, solidification type yoghourt preparation method provided in an embodiment of the present invention, by Wan Niangan, purslane, egg
Flower, peppermint and folium mori homogenate take juice after filtering filter residue, and watermelon peel, Kiwi berry, pears and sugar cane crushing take juice;
Specifically includes the following steps:
S101, the processing of ingredient: preparation filtered juice.Wan Niangan, purslane, frangipanis, peppermint and folium mori homogenate are refiltered
Fall filter residue and take juice, watermelon peel, Kiwi berry, pears and sugar cane crushing take juice.Each raw material is (gross mass 250g) by weight percentage:
It is Wan Niangan 5%~10%, radix polygonati officinalis 5%~8%, frangipanis 3%~5%, summer mushroom grass 3%~5%, purslane 3%~5%, thin
(or Kiwi berry, pears, sugarcane, note: this ingredient is that have Yoghourt a series of for lotus 8%~15%, mulberry leaf 5%~10%, watermelon peel
Different tastes) 6%~10%, starting milk 50%~65%, sucrose 3%~5%;
Milk bottle disinfection: S102 milk bottle is used boiling water boiling 15 minutes in stainless-steel pan;
S103, the purification of cow's milk: with specially designed centrifuge, the white blood cell removed in cow's milk is macroscopic with other
Foreign matter;
Normalising fat content: the skimmed milk of certain volume is added, or by dividing in S104 in the high cow's milk of fat content
It disembarks and isolates dilute cream from cow's milk, then mix a certain amount of dilute cream again in obtained skimmed milk;
S105, ingredient, the addition of sucrose: being heated to 60 DEG C or so for raw milk, and the sugarcane of 3%-5% is added in modulation cream
Sugar, after sugar dissolution, then filtering and impurity removing adds the filtered juice of step 1 preparation;
Two methods of heating and the appropriate combination of homogeneous are got up to handle, raw milk are first adjusted to 60 DEG C of left sides by S106, homogeneous
The right side carries out homogenization to cream in 8~10Mpa pressure then in homogenizer;
S107, sterilizing: there are two types of the sterilizing methods of the raw milk after homogeneous, and cream is heated to 90 DEG C, keeps the temperature 5min, or
It is placed in 80 DEG C of thermostat water baths and sterilizes 15 minutes, or use ultra high temperature short time sterilization method (keeping the temperature 2~3s at 135 DEG C);
Inoculation: S108 is added the working stock culture that inoculum concentration is 2~3%, is in the raw milk sterilized to 43~45 DEG C
The Mixed Microbes of streptococcus thermophilus and lactobacillus fermenti, the ratio of two kinds of bacterium are 1:1 or 2:1.The inoculum concentration of coccus is slightly some more, can make up
Since bacillus grows the shortcomings that producing acid and hindering coccus lazy weight caused by coccus growth;
S109, packing: in desinfection chamber, by the cow's milk culture medium containing lactic acid bacteria be first dispensed into sale vial or
In plastic small container, thermostatic chamber culture is sent into after capping, Yoghourt is made in fermentation in a reservoir.After cow's milk packing, upper vessel portion is stayed
Gap out wants as small as possible, and the time of operation wants short;
S110, fermentation: the container equipped with lactobacteria-containing cow's milk being placed in insulating box and is fermented, the temperature of insulating box
40~43 DEG C are maintained at, the time is 3~4 hours;
S111, cooling: fermentation ends should will be sour before Yoghourt shifting to be put into refrigerating chamber and carries out storage and Aging storage
Milk takes out from fermenting cellar, is cooled to 10 DEG C rapidly with cold wind hereinafter, the lactic acid bacteria in Yoghourt is made to stop growing;
S112, after-ripening: Yoghourt should be kept for 24 hours or more after forming grumeleuse at 4~7 DEG C;
S113, refrigeration: the Yoghourt through cooling treatment is housed in 2~5 DEG C, and preferably -1~0 DEG C of refrigerating chamber saves;
S114, taste: if there is smell, being likely to Yoghourt polluted miscellaneous bacteria.
As shown in Fig. 2, stirred yoghurt preparation method provided in an embodiment of the present invention, specifically includes the following steps:
S201, the processing of ingredient: preparation filtered juice.Wan Niangan, purslane, frangipanis, peppermint and folium mori homogenate are refiltered
Fall filter residue and take juice, watermelon peel, Kiwi berry, pears and sugar cane crushing take juice.Each raw material is (gross mass 250g) by weight percentage:
It is Wan Niangan 5%~10%, radix polygonati officinalis 5%~8%, frangipanis 3%~5%, summer mushroom grass 3%~5%, purslane 3%~5%, thin
(or Kiwi berry, pears, sugarcane, note: this ingredient is that have Yoghourt a series of for lotus 8%~15%, mulberry leaf 5%~10%, watermelon peel
Different tastes) 6%~10%, starting milk 50%~65%, sucrose 3%~5%;
Milk bottle disinfection: S202 milk bottle is used boiling water boiling 15 minutes in stainless-steel pan;
S203, the purification of cow's milk: utilizing specially designed centrifuge, and the white blood cell removed in cow's milk is visible with other naked eyes
Foreign matter;
Normalising fat content: the skimmed milk of certain volume is added, or by dividing in S204 in the high cow's milk of fat content
It disembarks and isolates dilute cream from cow's milk, then mix a certain amount of dilute cream again in obtained skimmed milk;
S205, ingredient: being heated to 60 DEG C or so for raw milk, and the sucrose of 3%-5% is then added in modulation cream, and sugar is molten
Then Xie Hou, filtering and impurity removing add the filtered juice of step 1 preparation;
Homogeneous: S206 two methods of heating and the appropriate combination of homogeneous is got up, raw milk is first adjusted to 60 DEG C or so, so
Afterwards in homogenizer, homogenization is carried out to cream in 8~10Mpa pressure;
S207, sterilizing: there are two types of the sterilizing methods of the raw milk after homogeneous, and cream is heated to 90 DEG C, keeps the temperature 5min, or
It is placed in 80 DEG C of thermostat water baths and sterilizes 15 minutes;Ultra high temperature short time sterilization method (2~3s is kept the temperature at 135 DEG C) can also be used;
Inoculation: S208 is added the working stock culture that inoculum concentration is 2~3%, is in the raw milk sterilized to 43~45 DEG C
The ratio of the Mixed Microbes of streptococcus thermophilus and lactobacillus fermenti, two kinds of bacterium is 1:1 or 2:1, and the inoculum concentration of coccus is slightly some more;
S209, fermentation: the container equipped with lactobacteria-containing cow's milk being placed in insulating box and is fermented, the temperature of insulating box
40~43 DEG C are maintained at, the time is 3~4 hours;
S210, stirring: being stirred into cup for the cow's milk containing lactic acid bacteria and contain in other containers, and product curd particle diameter is protected
It holds in 0.01~0.04mm size;
S211, packing: in desinfection chamber, by the cow's milk culture medium containing lactic acid bacteria be first dispensed into sale vial or
In plastic small container, thermostatic chamber culture is sent into after capping, Yoghourt is made in fermentation in a reservoir.After cow's milk packing, upper vessel portion is stayed
Gap out wants as small as possible, and the time of operation wants short;
S212, cooling: fermentation ends should will be sour before Yoghourt shifting to be put into refrigerating chamber and carries out storage and Aging storage
Milk takes out from fermenting cellar, is cooled to 10 DEG C or less rapidly with cold wind.
Combined with specific embodiments below and validity check is further described application principle of the invention.
Embodiment 1
Vitro detection:
Macrophage be the innate immunity initial defence line cell and its adjust acquired immunity thereafter and have inducing
Consequence.The Factor of Macrophage and inflammatory mediator of activation play an important role in generation, the development of inflammation,
So the adjusting of macrophage activation has become some means and methods for preventing diseases associated with inflammation.
Cell is by secreting or adjusting inflammatory factor such as platelet activating factor TNF-α (tumor necrosis factor α), hs-
CRP (hs-CRP) and IL-1 β (interleukin-1 beta) etc., to participate in, adjust, inducing inflammatory reaction.TNF-α is
Obvious one of the cell factor of inflammatory reaction, while other inflammatory factors such as IL-1 β etc. can be induced again and generate coordination and made
With.TNF-α, IL-1 β and hs-CRP have been widely used as test whether inflammation presence and its degree common index how.
The present invention is seen by establishing the external inflammatory model of lipopolysaccharides (LPS) stimulating expression of macrophage strain RAW246.7 activation
Examine the anti-inflammatory effect for the treatment of abscess of throat Yoghourt.RAW264.7 cell is cultivated, Yoghourt extract is previously added and is incubated for 2 hours, after
The LPS stimulation of final concentration of 200ng/ml is added, establishes cellular inflammation model, and establish sterile saline control group.LPS's
Induction, can lead to the variation of relevant inflammatory factors such as TNF-α, IL-1 β and hs-CRP secretory volume, by measuring cell supernatant
In various inflammatory factors secretory volume and cell in corresponding group express before and after modeling, to the change before and after Yoghourt extract
Change, can preliminary judgement Yoghourt whether there is anti-inflammatory effect.
Below with reference to solution and preparation, the invention will be further described.
Main solution and preparation:
1,1640 culture medium: 13.4g DMEM dry-type culture medium is dissolved with 90ml ultrapure water, magnetic agitation keeps dry powder complete
Fully dissolved adds 2.23g NaHCO3And 3.08g Hepes, adjustment pH value add water to be settled to 1000ml to 7.2~7.4,0.22 μm
It is dispensed after membrane filtration degerming, -20 DEG C of preservations.
2,0.25% trypsase: weighing trypsase 0.5g, is added in 200ml PBS, and magnetic agitation makes it completely
Dissolution, dispenses after 0.22 μm of membrane filtration degerming, -20 DEG C of preservations.
3, Yoghourt extract: 100ml Yoghourt is taken to carry out refrigerated centrifuge (10000r/min, 10min), with 0.2 μm of filter membrane two
Time, take supernatant.
Instrument:
Sorvall ST16R refrigerated centrifuge (Thermo Fishr Scientific company, the U.S.);Mouse hs-CRP
ELISA kit (R&D company, the U.S., lot number: 201207);Mouse TNF-α ELISA kit (R&D company, the U.S., lot number:
201207);Mouse IL-1 β ELISA kit (R&D company, the U.S., lot number: 201207).
Below with reference to cell culture, the invention will be further described.
1. cell culture
(1) source property macrophage strain RAW264.7 is incubated in RPMI1640 culture medium (containing 10% newborn bovine serum, 100 μ
G/ml streptomysin, 100 μ/ml penicillin).Condition of culture is 37 DEG C, and gas concentration lwevel 5% is continuous to cultivate.
(2) 0.25% trypsin digestion of cell, cold culture medium is added after being rounded under the microscope and stops digestion,
Centrifuging and taking precipitating is resuspended with culture medium after blowing and beating repeatedly, is inoculated in culture dish, is inoculated with initial density 2 × 105/ ml, culture is extremely
For testing after 80% fusion, serum-free processing in 12 hours makes cell synchronization before testing.
(3) Yoghourt extract is added by various concentration, is incubated for 2h in advance, 200ng/ml is added in solvent control DMSO afterwards
LPS (final concentration) stimulate different time, take supernatant culture respectively, cell is used for different Indexs measures.
2.MTT colorimetric determination administers abscess of throat Yoghourt to cytotoxicity
Principle: the entitled thiazolyl blue of MTT quotient, to be faint yellow, it can be by the succinate dehydrogenase in living cells mitochondria also
Original at slightly solubility bluish violet crystal violet object first a ceremonial jade-ladle, used in libation and be deposited in cell body, but MTT cannot be reduced to royal purple in dead cell
Color crystal.The crystallization can be had at 560-610nm after dimethyl sulfoxide (DMSO) or the acidification dissolution such as isopropanol one compared with
Wide maximum absorption peak can quantitative determine the light absorption at 570nm with microplate reader.Due to the production quantity and mitochondria of first a ceremonial jade-ladle, used in libation
Succinate dehydrogenase activity is positively correlated, and can reflect dehydrogenase activity with the size of absorbance, to reflect living cells indirectly
Quantity, living cells is more, and purple product is more, then light absorption (OD value) is higher.
Method: with 96 orifice plate culture cells, according to experimental group be added various concentration Yoghourt extract (0.8,4,20,
40,80 μM), at 37 DEG C, containing 5%CO2Incubator in be incubated for 18h, be added the MTT of final concentration of 0.5mg/ml, be incubated for 4h
Afterwards, it inhales and abandons supernatant, dimethyl sulfoxide (DMSO) is added in every hole, and shaken at room temperature 10min is sufficiently dissolved to purple crystal thing, uses
Full-automatic microplate reader reads OD value at 570nm, every group of 6 hole of repetition.Calculate cell survival rate.Cell survival rate=(detection
OD value/control wells OD value in hole) × 100%.
3. treating the influence (ELISA detection) that abscess of throat Yoghourt generates TNF-α to LPS stimulation RAW264.7 cell
(0.8,4,20 μM) is added by various concentration in Yoghourt extract, is incubated for 2h in advance, and other groups of addition solvents compare,
LPS (final concentration) the stimulation 18h that liquid removes addition 200ng/ml after Yoghourt is changed, supernatant culture solution is taken respectively, is placed in -20 DEG C of preservations
To detection.It is detected using the kit of commercialization, the concentration of culture solution TNF-α is groped in experiment in advance, to be diluted to kit
Detection range.Each sample does multiple holes measurement.Determination step is as follows:
(1) sample 0.1ml is added in every hole, and ELISA Plate reacts 90 minutes plus lid, 37 DEG C.
(2) with the liquid got rid of in ELISA Plate after reacting, then against blotting paper clap it is several under, do not wash.
(3) ready biotin anti-TNF-α antibody working solution is sequentially added by every hole 0.1ml.37 DEG C are reacted 60 points
Clock.
(4) every hole is added 0.01M PBS 0.35ml and washs 3 times, impregnates 1 minute or so every time.
(5) ready ABC working solution is sequentially added by every hole 0.1ml, (TMB blank develops the color except hole).37 DEG C anti-
It answers 30 minutes.
(6) every hole is added 0.01M PBS 0.35ml and washs 5 times, impregnates 1~2 minute or so every time.
(7) it sequentially adds by every 90 μ l of hole in 37 DEG C of balances, 30 minutes TMB developing solutions, 37 DEG C are protected from light 15 points
Clock.
(8) TMB terminate liquid is sequentially added by every hole 0.1ml, blue turns yellow at this time.OD is measured in 50nm with microplate reader
Value.Corresponding concentration is calculated according to standard curve.
4. cell supernatant hs-CRP is detected
Using mouse hs-CRP ELISA kit, operated in strict accordance with kit specification, steps are as follows:
(1) dilution of standard items and sample-adding: 10 hole of standard sample wells is set on enzyme mark coating plate, is added respectively in sub 1,2 holes
100 μ l of standard items is mixed then in 50 μ l of the 1st, 2 Kong Zhongjia standard dilutions;Then 100 μ l points are respectively taken from the 1st, 2 holes
It is not added to the 3rd, 4 holes, adds 50 μ l of standard dilutions respectively in the 3rd, 4 holes, mixes;Then 50 μ are respectively taken in the 3rd, 4 holes
L is discarded, then respectively takes 50 to be added separately in the 5th, 6 holes, adds 50 μ l of standard dilutions respectively in the 5th, 6 holes, is mixed;From the 5th,
It respectively takes 50 to be added separately in 7,8 holes in 6 holes, adds 50 μ l of standard dilutions respectively in 7,8 holes, mix;From the 7th, 8 holes
50 μ l are respectively taken to be added separately in the 9th, 10 holes, in the 9th, 10 holes respectively plus 50 μ l of standard dilutions is mixed, then the
9,50 μ l are respectively taken to discard in 10 holes.Each hole adds sample size to be 50 μ l after dilution, and concentration is respectively 6 μ l/L, 4 μ g/L, 2 μ g/L, 1
μg/L、0.5μg/L。
(2) it is loaded: white hole (sample and enzyme marking reagent being not added, remaining each step operation is identical), sample to be tested is respectively set
Hole.Respectively add 40 μ l of sample diluting liquid in sample to be tested hole, then adds 10 μ l of sample to be tested (the final dilution of sample respectively again
It is 5 times).Sample is added on microplate reader plate hole bottom by sample-adding, is not touched hole wall as far as possible, is shaked gently mixing.
(3) it incubates: being placed on 37 DEG C of electro-heating standing-temperature cultivator with sealing plate film sealing plate and incubate 30 minutes.
(4) match liquid: 30 (20 times of 48T) times concentrated cleaning solutions distilled water 30 (20 times of 48T) times is diluted into standby
With.
(5) board-washing: taking out ELISA Plate, carefully throw off sealing plate film, discard liquid, dries, and board-washing liquid is filled it up in every hole, stands 30
It is discarded after second, is so repeated 5 times, pats dry.
(6) enzyme: every hole is added 50 μ l of enzyme marking reagent, except blank well.
(7) it incubates: being placed on 37 DEG C of electro-heating standing-temperature cultivator with sealing plate film sealing plate and incubate 30 minutes.
(8) board-washing: taking out ELISA Plate, carefully throw off sealing plate film, discard liquid, dries, and board-washing liquid is filled it up in every hole, stands 30
It is discarded after second, is so repeated 5 times, pats dry.
(9) develop the color: 50 μ l color developing agent A are first added in every hole, add 50 μ l color developing agent B, and gently concussion mixes, and 37 DEG C are protected from light
Colour developing 15 minutes.
(10) terminate: every hole adds 50 μ l color development stopping of terminate liquid to react.
(11) it is returned to zero with blank well, 450nm wavelength sequentially measures each hole absorbance.15 minutes after measurement Ying Jia terminate liquid
Within carry out.
(12) it calculates: according to the concentration of standard items and corresponding OD value, calculating the linear regression equation of standard curve,
According to the OD value of sample, corresponding sample concentration is calculated on regression equation, ultimate density is actual concentrations multiplied by dilution times
Number.
5. cell supernatant IL-1 β is detected
Using mouse IL-1 β ELISA kit, operated in strict accordance with kit specification, steps are as follows:
(1) dilution of standard items and sample-adding: 10 hole of standard sample wells is set on enzyme mark coating plate, is added respectively in sub 1,2 holes
100 μ l of standard items is mixed then in 50 μ l of the 1st, 2 Kong Zhongjia standard dilutions;Then 100 μ l points are respectively taken from the 1st, 2 holes
It is not added to the 3rd, 4 holes, adds 50 μ l of standard dilutions respectively in the 3rd, 4 holes, mixes;Then 50 μ are respectively taken in the 3rd, 4 holes
L is discarded, then respectively takes 50 to be added separately in the 5th, 6 holes, adds 50 μ l of standard dilutions respectively in the 5th, 6 holes, is mixed;From the 5th,
It respectively takes 50 to be added separately in 7,8 holes in 6 holes, adds 50 μ l of standard dilutions respectively in 7,8 holes, mix;From the 7th, 8 holes
50 μ l are respectively taken to be added separately in the 9th, 10 holes, in the 9th, 10 holes respectively plus 50 μ l of standard dilutions is mixed, then the
9,50 μ l are respectively taken to discard in 10 holes.Each hole adds sample size to be 50 μ l after dilution, and concentration is respectively 90ng/L, 60ng/L, 30ng μ
g/L、15ng/L、7.5ng/L。
(2) it is loaded: white hole (sample and enzyme marking reagent being not added, remaining each step operation is identical), sample to be tested is respectively set
Hole.Respectively add 40 μ l of sample diluting liquid in sample to be tested hole, then adds 10 μ l of sample to be tested (the final dilution of sample respectively again
It is 5 times).Sample is added on microplate reader plate hole bottom by sample-adding, is not touched hole wall as far as possible, is shaked gently mixing.
(3) it incubates: being placed on 37 DEG C of electro-heating standing-temperature cultivator with sealing plate film sealing plate and incubate 30 minutes.
(4) match liquid: 30 (20 times of 48T) times concentrated cleaning solutions distilled water 30 (20 times of 48T) times is diluted into standby
With.
(5) board-washing: taking out ELISA Plate, carefully throw off sealing plate film, discard liquid, dries, and board-washing liquid is filled it up in every hole, stands 30
It is discarded after second, is so repeated 5 times, pats dry.
(6) 50 μ l of enzyme marking reagent is added in hole, except blank well.
(7) it incubates: being placed on 37 DEG C of electro-heating standing-temperature cultivator with sealing plate film sealing plate and incubate 30 minutes.
(8) board-washing: taking out ELISA Plate, carefully throw off sealing plate film, discard liquid, dries, and board-washing liquid is filled it up in every hole, stands 30
It is discarded after second, is so repeated 5 times, pats dry.
(9) develop the color: 50 μ l color developing agent A are first added in every hole, add 50 μ l color developing agent B, and gently concussion mixes, and 37 DEG C are protected from light
Colour developing 15 minutes.
(10) hole adds 50 μ l color development stopping of terminate liquid to react.
(11) it is returned to zero with blank well, 450nm wavelength sequentially measures each hole absorbance.15 minutes after measurement Ying Jia terminate liquid
Within carry out.
(12) it calculates: according to the concentration of standard items and corresponding OD value, calculating the linear regression equation of standard curve,
According to the OD value of sample, corresponding sample concentration is calculated on regression equation, ultimate density is actual concentrations multiplied by dilution times
Number.Compared with inflammatory model group, Yoghourt extract 1,2,3 can reduce the level of mouse TNF-α, IL-1 β and hs-CRP, thus
Play the role of anti-inflammatory.Yoghourt extract doses are higher, and the difference moon is significant, and anti-inflammatory effects are more significant.
Each group TNF-α, hp-CRP, IL-1 β are horizontal
Below with reference to vivo detection, the invention will be further described.
Embodiment 2
Vivo detection:
Mouse method of inspection:
Mice caused by dimethylbenzene xylene auricle edema model
Mouse 40 is only randomly divided into 4 groups, i.e. physiological saline model group, Yoghourt extract low (125mg/kg), high dose
Group (500mg/kg), positive control medicine (dexamethasone 10mg/kg), every group 10.Mouse is deprived of food but not water 12h before testing,
Each group mouse presses 0.2ml/10g gastric infusion, and 1 time a day, total 7d, after the last administration 1h, each group mouse is in auris dextra tow sides
It coats the dimethylbenzene (1.15ml/ only) that concentration is 100% and causes scorching, cause after inflammation 30min to sweep away left and right ear with punch same
The disk at position using two auricle quality difference values as inflammation swelling, and calculates swelling inhibiting rate in weighing on assay balance: swollen
Swollen inhibiting rate=(model group swelling-administration group swelling)/model group swelling × 100%.Yoghourt extract high concentration group
To the swelling inhibiting rate of Mice Auricle up to 38.63%.
The influence of Yoghourt extract paraxylene cause mice auricle swelling
Treatment abscess of throat Yoghourt Shi Yingxian of the invention is eaten in mouth containing 5~10s, then is slowly swallowed.
Application principle of the invention is further described below with reference to pharmacological analysis.
Purslane of the invention is the young young stem and leaf of portulacaceous plant purslane, and China, various regions, north and south produce.Property is fertilizer favorite
Fertile soil earth, drought-enduring also waterlogging, viability is strong, is born in vegetable garden, farmland, roadside, is field common weed.Purslane is clearing heat and detoxicating,
Li Shui dries, and dissipates blood detumescence, dust-collection sterilization, anti-inflammatory analgetic, blood-stanching and blood-cooling.Cure mainly dysentery, enteritis, ephritis, postpartum uterine hemorrhage,
Hematochezia, the illnesss such as mazoitis.
Frangipanis settles China and has centuries history, and just there is the frangipanis of one plant of more than 400 years of growth in Pinghu Town of Shenzhen Region street
Ancient tree.The flower and bark of frangipanis can be used as medicine, can be clearing heat and detoxicating, moistening lung to arrest cough, in In Guangdong Province often by the chicken of white
Egg flower, which is dried, makees antipyretic beverage, is popular, while flower can also extract aromatic oil, is used as modulation cosmetics and advanced perfume (or spice)
Soap.According to the latest news, the sap of frangipanis can treat a kind of by skin caused by HIV infection or anticancer drug and electrotherapy
Disease.Frangipanis is one of five flowers in the famous herbal tea five-flowered tea in Guangdong, cool in nature, sweet in flavor, light;Return large intestine, stomach meridian, there is moistening lung
The effect of removing toxic substances, clearing heat and expelling damp, laxation.As " south of the Five Ridges gather medicinal herbs record " says that it " can control damp-heat diarrhea, inner urgency tongue weight, and energy moistening lung.
Summer mushroom grass is also known as ajuga decumbens, clarke boea herb, POXUE DAN.1 year or biennial herb, high 10~30cm.Prunella vulgaris
For Lamiales Lamiaceae plant.It usually takes partial desiccation fruit ear to be used as medicine in summer, but makes in the common herb in TaiWan, China market
With.Prunella vulgaris beverage all on sale is spread in general herbal tea.Mainly it is grown on sparse woods, deserted mountain, ridge and roadside, the month at florescence 4-6, fruit
Month phase 7-10.Due to i.e. withered after this careless Summer Solstice, therefore there is this name.Bitter, acrid, cold.Enter liver, gallbladder channel.Its medical value has following several
Point: red eye, swell pain, headache improving eyesight of 1. relieving inflammation or internal heat: are controlled.Prunella vulgaris 2. clearing away the liver-fire, blood pressure lowering: high blood pressure, hyperlipidemia, high blood viscosity are controlled
And hyperglycemia.3. mass dissipating and swelling eliminating: controlling scrofula, goiter, acute mastitis swelling and pain.Clearing liver, dissipating bind, diuresis;Control seasonal febrile diseases, acute mastitis, mesh pain, Huang
The diseases such as subcutaneous ulcer, stranguria syndrome, hypertension;Ye Kedai tea.
Radix polygonati officinalis is liliaceous plant.Elongated cylindrical, slightly flat, rare branch, surface yellow-white or fallow is translucent,
Have the link of vertical wrinkle and micro- protuberance, there is the mark of fibrous root and discoid stem trace of white round point shape.The dry meat of radix polygonati officinalis is in root shape
Stem is Polygonatum herbaceos perennial, is large Chinese medicine.Gas is micro-, sweet in flavor, the stickness chewed.Nourishing yin to moisten dryness is cured mainly, is promoted the production of body fluid only
Yearningly.Hurt for lung stomach-Yin, hyperglycemia, cough caused by dryness-heat, dry throat and mouth, Heat Diabetes.
Mulberry leaf are the dried leafs of moraceae plants mulberry, are the conventional foods of silkworm.Mulberry-leaf extract 1-Deoxynojirimycin and summer mushroom
Grass, which extracts flavonoid substances and combines, forms a kind of novel substance --- it is plain (cics) to wash the clear sugar of pancreas, suitable for control hypoglycemic, blood lipid,
The effects of anti-inflammatory.Dispelling wind and heat from the body;Clearing lung-heat;Improving eyesight.Main anemopyretic cold;Wind-warm syndrome is from the beginning of, fever and headache, perspiration and aversion to wind, pectoralgia of coughing;
Or dryness of the lung dry cough without phlegm;Dry throat and mouth;It is disturbed on wind-heat and liver-yang;Red eye, swell pain.For anemopyretic cold, lung-heat type cough, dizzy head
Bitterly, red eyes and dim-sighted." Shandong Chinese medicine ": soothing sore throat, swelling and aching of gum, head edema.Clearing away the lungheat and moisturizing: be used for lung-heat type cough: the product are bitter
Cold eliminating heat from the lung, sweet cold benefiting yin, cool moistening lung dryness, thus can be used for dry-heat impairing lung, dry cough lack mulberry-leaf extract 1-Deoxynojirimycin and
Summer mushroom grass, which extracts flavonoid substances and combines, forms a kind of novel substance --- it is plain (cics) to wash the clear sugar of pancreas, suitable for control it is hypoglycemic,
Blood lipid, it is anti-inflammatory the effects of.For hyperlipidemia, hyperglycemia, diabetes, fatty liver, coronary heart disease, hypertension, pharyngitis, first, B-mode liver
The rehabilitation of the scorching postoperative chemicotherapy patient for the treatment of and cancer has extraordinary booster action.
Peppermint, alias HERBA MENTHAE.For Labiatae mint peppermint, (herbaceos perennial, stem have tetragonous, leaf pair
Raw, Hua Chenghong, white or lavender, stem and leaf have refrigerant fragrance, can be used as medicine, or are used for food.It is pungent, cool, dispelling wind and heat from the body,
Head clearing.Anemopyretic cold is cured mainly, is had a headache, abscess of throat is lossless, wind-fire red eye, rubeola, and skin, which is itched, waits diseases.Peppermint is virtue
Fragrant compounds of group, peppermint oil and menthol are widely used in medicine, and are daily necessities and food industry primary raw material.This product lightly floats
Rise floating, awakening consciousness, the kind evacuation part of the body cavity above the diaphragm housing the heart and lungs wind-heat of function, refresh oneself, throat.It is attacked in wind-heat with controlling, headache and hot eyes, polygamy closes mulberry
Leaf, chrysanthemum, fructus viticis are equally used;Stop up Sheng with wind-heat is controlled, abscess of throat is often equivalent with campanulaceae, licorice, bombyx batryticatus, schizonepeta, radix saposhnikoviae
With.
Watermelon peel, alias Mesocarpium citrulli.Source is the outside rind of cucurbitaceous plant watermelon.It gathers and processes 7~August and collects watermelon
Skin is pruned internal layer soft, is dried;Also have to peel off on outside green peel and only take intermediate portion person.Character, dried fruit thin skin and
Curling, not of uniform size at tubular or irregular shape, outer surface yellow, yellow green or dark brown;Inner surface has netted vascular bundle
Strain line.Matter is crisp, frangibility.Remove outer layer green peel person, be in irregular strip and block, shrinkage and crimp, surface lark, have obvious
Wrinkle and netted vascular bundle.Gas is micro-, lightly seasoned.The urea that citrulling contained in watermelon peel can be promoted in rats'liver is formed, thus
It, can be to treat nephritic dropsy, hepatopathy jaundice and diabetes with diuresis.In addition there are antipyretic, promotion wound healings
And promote effect of human skin metabolism.The clear heat of major function is antipyretic, quenches the thirst, diuresis.For hot summer weather polydipsia, urine
Deficient, oedema, aphthae.
Soft, the sweet mouthfeel of Kiwi berry.Taste is described as the mixing of strawberry, banana, pineapple three.Kiwi berry
Except containing the microelements such as organic matters and calcium, potassium, selenium, zinc, germanium such as actinidine, proteolytic enzyme, tannin pectin and carbohydrate
Outside 17 kinds of amino acid of needed by human body, vitamin C also rich in, grape acid, fructose, citric acid, malic acid, fat.It can
To treat dysphoria with smothery sensation, quench one's thirst, jaundice, vomiting, diarrhea, urolithiasis, the diseases such as arthralgia, and there are also the effects of anti-aging.Modern times doctor
Research and analyse, and kiwifruit fruit contains carbohydrate, and Amino Acids in Proteins is abundant, and 12 kinds of protease, vitamin B1, C, Hu Luo
The Multiple components such as Bu Su and calcium, phosphorus, iron, sodium, potassium, magnesium, chlorine, pigment.Its Vitamin C content is five to six in equivalent citrus
Times.Kiwi berry acid, sweet in flavor cold, appropriate eat also has the effect of very effective fluid dryness, antipyretic relieving restlessness.For larynx
Throat pain eats any fruit great question, and Kiwi berry is absolutely optimal selection.
Pears are rich in sugar, protein, fat, carbohydrate and multivitamin, play an important role, can change to human health
Kind respiratory system and lung function, there is the effect of moistening lung, can reduce lung by air dust and flue dust influenced.Pears have life
The effect of saliva quenches the thirst, is relieving cough and reducing sputum, heat-clearing and fire-reducing, therefore it is very suitable to the patients of winter fever and interior heat.It is especially right
For the patient of the symptoms such as some autumn cough with lung heat, dry throat larynx pain, dry feces, autumn pear also has very effective help
Digestion, antipyretic diuresis.In usually life, regardless of suitable a little autumn pears can be eaten either with or without symptoms such as sore throats more.
Sugarcane taste sweet and neutral, it is nontoxic.Main lower gas helps temper in, and profit large intestine, dissolving phlegm is quenched the thirst, and removes ambition dysphoria with smothery sensation, removing toxic substances.It is sweet
Sugarcane energy purging intense heat heat, antipyretic to quench the thirst, He Zhongkuan diaphragm, fluid dryness help spleen stomach invigorating, diuresis, nourishing and other effects.It can be used for dry tongue
Dry, body fluid deficiency, difficult urination, constipation, gastric disorder causing nausea vomiting, indigestion, has a fever thirsty.Drinking raw property of sugar-cane juice is sweet cold, fits
Suitable consumption of body fluid caused by febrile disease, restlessness and thirst, body heat urinates red, xeropulmonary cough, and the raw sugarcane juice of febrile disease drink is best.Sphagitis patient eat raw with it is ripe
Food all may be used.Prepared food sugar-cane juice gets up benefiting action to sphagitis patient.
The above is only the preferred embodiments of the present invention, and is not intended to limit the present invention in any form,
Any simple modification made to the above embodiment according to the technical essence of the invention, equivalent variations and modification, belong to
In the range of the technology of the present invention invention.
Claims (5)
1. a kind of refrigerant Yoghourt for controlling abscess of throat, which is characterized in that the refrigerant Yoghourt percentage by weight for controlling abscess of throat
Than are as follows: Wan Niangan 5%~10%, radix polygonati officinalis 5%~8%, summer mushroom grass 3%~5%, frangipanis 3%~5%, purslane 3%~
5%, peppermint 8%~15%, mulberry leaf 5%~10%, watermelon peel 6%~10%, starting milk 50%~65%, sucrose 3%~
5%, lactobacillus fermenti 6%~10% and streptococcus thermophilus 3%~9% form.
2. a kind of solidification type yoghourt preparation method for the refrigerant Yoghourt for controlling abscess of throat as described in claim 1, which is characterized in that
The solidification type yoghourt preparation method, comprising:
Step 1, the processing of ingredient: preparation filtered juice;By Wan Niangan, purslane, radix polygonati officinalis, summer mushroom grass, peppermint and folium mori homogenate after
It filters filter residue and takes juice, watermelon peel, Kiwi berry, pears and sugar cane crushing take juice;Take each raw material by weight percentage: Wan Niangan 5%~
10%, radix polygonati officinalis 5%~8%, frangipanis 3%~5%, summer mushroom grass 3%~5%, purslane 3%~5%, peppermint 8%~15%,
Mulberry leaf 5%~10%, watermelon peel 7%~10%, starting milk 50%~65%, sucrose 3%~5%;
Milk bottle disinfection: step 2 milk bottle is used boiling water boiling 15 minutes in stainless-steel pan;
Step 3, the purification of cow's milk: with specially designed centrifuge, the white blood cell removed in cow's milk is macroscopic different with other
Object;
Normalising fat content: step 4 the skimmed milk of certain volume is added in the high cow's milk of fat content, or passes through separation
Machine isolates dilute cream from cow's milk, then mixes a certain amount of dilute cream again in obtained skimmed milk;
Step 5, ingredient: being heated to 60 DEG C or so for raw milk, and the sucrose of 3%-5% is added in modulation cream, after sugar dissolution,
Then filtering and impurity removing adds the filtered juice of step 1 preparation;
Step 6, homogeneous: two methods of heating and the appropriate combination of homogeneous being got up to handle, raw milk is first adjusted to 60 DEG C or so,
Then in homogenizer, homogenization is carried out to cream in 8~10Mpa pressure;
Step 7, sterilizing: there are two types of the sterilizing methods of the raw milk after homogeneous, and cream is heated to 90 DEG C, keeps the temperature 5 minutes, or set
It sterilizes 15 minutes in 80 DEG C of thermostat water baths, or uses ultra high temperature short time sterilization method, keep the temperature 2~3 seconds at 135 DEG C;
Inoculation: working stock culture is added, inoculum concentration is 2~3%, thermophilic in step 8 in the raw milk sterilized to 43~45 DEG C
The Mixed Microbes of streptococcus and lactobacillus fermenti, the ratio of two kinds of bacterium are 1:1 or 2:1;
Packing: cow's milk culture medium containing lactic acid bacteria in desinfection chamber, is first dispensed into vial or the modeling of sale by step 9
Expect in small container, thermostatic chamber culture is sent into after capping, and Yoghourt is made in fermentation in a reservoir;
Step 10, fermentation: the container equipped with lactobacteria-containing cow's milk being placed in insulating box and is fermented, the temperature 40 of insulating box
~43 DEG C, the time is 3~4 hours;
Step 11, cooling: fermentation ends should will be sour before Yoghourt shifting to be put into refrigerating chamber and carries out storage and Aging storage
Milk takes out from fermenting cellar, is cooled to 10 DEG C rapidly with cold wind, and the lactic acid bacteria in Yoghourt is made to stop growing;
Step 12, after-ripening: Yoghourt should be kept for 24 hours after forming grumeleuse at 4~7 DEG C;
Step 13, refrigeration: the Yoghourt through cooling treatment is housed in 2~5 DEG C, and -1~0 DEG C of refrigerating chamber saves;
Step 14, taste: observation Yoghourt state tastes yogurt flavour.
3. a kind of stirred yoghurt preparation method for the refrigerant Yoghourt for controlling abscess of throat as described in claim 1, which is characterized in that
The stirred yoghurt preparation method, comprising:
Step 1, the processing of ingredient: preparation filtered juice;By Wan Niangan, purslane, frangipanis, peppermint and folium mori homogenate after filtering
Filter residue takes juice, and watermelon peel, Kiwi berry, pears and sugar cane crushing take juice;Take each raw material by weight percentage: Wan Niangan 5%~10%,
Radix polygonati officinalis 5%~8%, frangipanis 3%~5%, summer mushroom grass 3%~5%, purslane 3%~5%, peppermint 8%~15%, mulberry leaf
5%~10%, watermelon peel 6%~10%, starting milk 50%~65%, sucrose 3%~5%;
Milk bottle disinfection: step 2 milk bottle is used boiling water boiling 15 minutes in stainless-steel pan;
Step 3, the purification of cow's milk: utilizing centrifuge, removes the foreign matter in cow's milk;
Normalising fat content: step 4 the skimmed milk of certain volume is added in the high cow's milk of fat content, or passes through separation
Machine isolates dilute cream from cow's milk, then mixes a certain amount of dilute cream again in obtained skimmed milk;
Step 5, ingredient: being first heated to 60 DEG C for raw milk, and the sucrose of 3%-5%, sugar dissolution are then added in modulation cream
Afterwards, then filtering and impurity removing adds the filtered juice of step 1 preparation;
Step 6, homogeneous: two methods of heating and the appropriate combination of homogeneous being got up to handle, raw milk is first adjusted to 60 DEG C or so,
Then in homogenizer, homogenization is carried out to cream in 8~10Mpa pressure;
Sterilizing: cream is heated to 90 DEG C, keeps the temperature 5 minutes, or be placed in 80 DEG C of thermostat water baths and sterilize 15 minutes by step 7;Or
2~3 seconds are kept the temperature at 135 DEG C with ultra high temperature short time sterilization method;
Inoculation: working stock culture is added, inoculum concentration is 2~3%, thermophilic in step 8 in the raw milk sterilized to 43~45 DEG C
The Mixed Microbes of streptococcus and lactobacillus fermenti, the ratio of two kinds of bacterium are 1:1 or 2:1;
Step 9, fermentation: the container equipped with lactobacteria-containing cow's milk being placed in insulating box and is fermented, the temperature 40 of insulating box
~43 DEG C, the time is 3~4 hours;
Step 10, stirring: being stirred into cup for the cow's milk containing lactic acid bacteria and contain in other containers, and curd particle diameter 0.01~
0.04mm;
Step 11, packing: in desinfection chamber, by the cow's milk culture medium containing lactic acid bacteria be first dispensed into sale vial or
In plastic small container, thermostatic chamber culture is sent into after capping, Yoghourt is made in fermentation in a reservoir;
Step 12, cooling: fermentation ends should will be sour before Yoghourt shifting to be put into refrigerating chamber and carries out storage and Aging storage
Milk takes out from fermenting cellar, is cooled to 10 DEG C rapidly with cold wind.
4. a kind of refrigerant Yoghourt of children prepared using the refrigerant Yoghourt for controlling abscess of throat described in claim 1.
5. a kind of refrigerant Yoghourt of person in middle and old age prepared using the refrigerant Yoghourt for controlling abscess of throat described in claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811268967.2A CN109479958A (en) | 2018-10-29 | 2018-10-29 | A kind of refrigerant Yoghourt and preparation method thereof for controlling abscess of throat |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811268967.2A CN109479958A (en) | 2018-10-29 | 2018-10-29 | A kind of refrigerant Yoghourt and preparation method thereof for controlling abscess of throat |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109479958A true CN109479958A (en) | 2019-03-19 |
Family
ID=65693329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811268967.2A Pending CN109479958A (en) | 2018-10-29 | 2018-10-29 | A kind of refrigerant Yoghourt and preparation method thereof for controlling abscess of throat |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109479958A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103766484A (en) * | 2012-10-23 | 2014-05-07 | 胡楚阳 | Watermelon peel lactic acid beverage and preparation method thereof |
CN106962484A (en) * | 2017-05-03 | 2017-07-21 | 贵阳中医学院 | Peppermint extract solution, peppermint Yoghourt and preparation method thereof |
-
2018
- 2018-10-29 CN CN201811268967.2A patent/CN109479958A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103766484A (en) * | 2012-10-23 | 2014-05-07 | 胡楚阳 | Watermelon peel lactic acid beverage and preparation method thereof |
CN106962484A (en) * | 2017-05-03 | 2017-07-21 | 贵阳中医学院 | Peppermint extract solution, peppermint Yoghourt and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103098917B (en) | Processing method of bamboo-leaf bamboo-juice fragrant flower healthy tea | |
CN102552462B (en) | Effervescent preparation as well as preparation method and application thereof | |
CN103622111B (en) | The preparation method of gold shaddock Oryza glutinosa vinegar drink and the golden shaddock Oryza glutinosa vinegar drink obtained by the method | |
CN101427773A (en) | Camellia chrysantha cold tea and producing method thereof | |
CN104970131A (en) | Health disease-treating, beauty-maintaining, young-keeping and long-life tea and preparation technology thereof | |
CN104522455A (en) | Saussurea involucrate culture honey cream and preparation method thereof | |
CN106434157A (en) | Traditional Chinese medicinal distiller's yeast and preparation method | |
CN103919205B (en) | A kind of lactobacillus-fermented grapefruit juice beverage and preparation method thereof | |
CN109125516B (en) | A group of herbal tea, and its preparation method and application | |
CN106235318A (en) | The method preparing ferment for primary raw material with Flos Lonicerae, Rhizoma Curcumae Longae | |
CN102177996B (en) | Semen cannabis laxative tea and preparation method thereof | |
CN105851390A (en) | Rhizoma gastrodiae, Flos chrysanthemi and Momordica grosvenori tea and making method thereof | |
CN108813501A (en) | With the relieving cough and reducing sputum health honey paste relievingd asthma and adjust function of human body of clearing heat and moistening lung | |
CN104041632A (en) | Beautification and health-protection tea and preparation method thereof | |
CN103750478B (en) | Prostate health functional drink | |
KR20200094528A (en) | Healthful mixed tea development using fermented herbs, fruits and shiitake | |
CN109479958A (en) | A kind of refrigerant Yoghourt and preparation method thereof for controlling abscess of throat | |
CN105124076A (en) | Healthy tea capable of moistening throat and preparing method thereof | |
CN106418498A (en) | Method for preparing enzyme by using lemons and galangal as main materials | |
CN105639458A (en) | Preparation method of probiotics-containing barley seedling xylitol nutritional powder | |
Hedley | A Herbal Book of Making and Taking | |
CN104686886A (en) | Efficient saussurea involucrate culture and honey paste and preparation method thereof | |
CN104719912A (en) | Snow lotus culture-honey paste with relatively high biological activity and preparation method of snow lotus culture-honey paste | |
CN104642607A (en) | Low-sugar gingko tea drink and preparation method thereof | |
CN109588519A (en) | A kind of tea-drinking addition concentration stock solution and preparation and concocting method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190319 |